In Vitro Diagnostics Market to Reach USD 128.18 Billion by 2033: New Report Reveals Key Growth Drive

PROVIDENCE, R.I. - March 11, 2026 - PRLog -- Market Research Port has published a comprehensive new study on the In Vitro Diagnostics Market, projecting significant expansion from USD 106.29 billion in 2025 to USD 128.18 billion by 2033, at a steady CAGR of 2.40% during the forecast period.

The global IVD market size is witnessing accelerated momentum as healthcare systems worldwide prioritize early disease detection, preventive medicine, and precision diagnostics. Rising chronic disease burden including diabetes, cardiovascular disorders, and cancer continues to drive demand for advanced laboratory diagnostic testing.

Why the In Vitro Diagnostics Industry Is Expanding

The shift toward point-of-care diagnostics, decentralized testing, and molecular diagnostic technologies is reshaping how diseases are detected and managed. Key factors fueling IVD market growth include:

• Increasing prevalence of infectious diseases and chronic conditions
• Rapid adoption of next-generation sequencing and automated lab platforms
• Growing demand for home-based diagnostic testing and self-testing kits
• Expanding healthcare infrastructure across Asia-Pacific and emerging economies

IVD Market Segmentation Highlights

The in vitro diagnostics market share is dominated by Reagents & Kits (65–69%), followed by Instruments (~25%) and Software & Services. By technology, immunoassay diagnostics and molecular diagnostics lead adoption, with molecular diagnostics being the fastest-growing segment due to superior disease detection precision.

Request a Free Sample Report Overview: https://marketresearchport.com/request-sample/?rid=648

By application, infectious disease testing holds the largest share, followed by oncology diagnostics, cardiology, diabetes testing, and genetic testing. Reflecting the rising need for clinical diagnostic solutions across multiple therapeutic areas.

Regional Outlook

North America commands 38–43% of the global IVD diagnostics market, supported by advanced healthcare infrastructure and strong R&D investment. Europe remains a mature, regulation-driven market, while Asia-Pacific IVD market growth is expected to outpace other regions through 2033, fueled by rising healthcare spending and population growth.

Competitive Landscape

Leading players operating in the in vitro diagnostics industry include Abbott, F. Hoffmann-La Roche, Siemens Healthineers, Bio-Rad Laboratories, QIAGEN, BD, Danaher, and Quest Diagnostics. All innovating aggressively in rapid diagnostic testing, companion diagnostics, and AI-powered laboratory automation.

Access the Full Report

The full In Vitro Diagnostics Market Outlook & Forecast 2026–2033: Covering 189 pages of segmentation data, regional analysis, competitive benchmarking, and technology forecasts is now available.

Read the full report: https://marketresearchport.com/reports/in-vitro-diagnostics-market-outlook-forecast-2026-2033/

About Market Research Port Market Research Port is a leading provider of market intelligence reports across healthcare, pharmaceuticals, and life sciences sectors, helping businesses make data-driven strategic decisions.